GAS5 rs2067079 and miR-137 rs1625579 functional SNPs and risk of chronic hepatitis B virus infection among Egyptian patients
Abstract Hepatitis B virus (HBV) infection is a significant health issue worldwide.. We attempted to fulfill the molecular mechanisms of epigenetic and genetic factors associated with chronic HBV (CHBV). Expression levels of the lncRNA growth arrest-specific 5 (GAS5) and miR-137 and their correspond...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f70bc44957ef46e89717d93b6c4b3c51 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f70bc44957ef46e89717d93b6c4b3c51 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f70bc44957ef46e89717d93b6c4b3c512021-12-02T19:16:14ZGAS5 rs2067079 and miR-137 rs1625579 functional SNPs and risk of chronic hepatitis B virus infection among Egyptian patients10.1038/s41598-021-99345-22045-2322https://doaj.org/article/f70bc44957ef46e89717d93b6c4b3c512021-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-99345-2https://doaj.org/toc/2045-2322Abstract Hepatitis B virus (HBV) infection is a significant health issue worldwide.. We attempted to fulfill the molecular mechanisms of epigenetic and genetic factors associated with chronic HBV (CHBV). Expression levels of the lncRNA growth arrest-specific 5 (GAS5) and miR-137 and their corresponding SNPs, rs2067079 (C/T) and rs1625579 (G/T) were analyzed in 117 CHBV patients and 120 controls to investigate the probable association between these biomarkers and CHBV pathogenesis in the Egyptian population. Serum expression levels of GAS5 and miR-137 were significantly down-regulated in cases vs controls. Regarding GAS5 (rs2067079), the mutant TT genotype showed an increased risk of CHBV (p < 0.001), while the dominant CC was a protective factor (p = 0.004). Regarding miR-137 rs1625579, the mutant genotype TT was reported as a risk factor for CHBV (p < 0.001) and the normal GG genotype was a protective factor, p < 0.001. The serum GAS5 was significantly higher in the mutant TT genotype of GAS5 SNP as compared to the other genotypes (p = 0.007). Concerning miR-137 rs1625579, the mutant TT genotype was significantly associated with a lower serum expression level of miR-137 (p = 0.018). We revealed the dysregulated expression levels of GAS5 and miR-137 linked to their functioning SNPs were associated with CHBV risk and might act as potential therapeutic targets.Rania H. MahmoudEnas Mamdouh HefzyOlfat G. ShakerTarek I. AhmedNoha K. AbdelghaffarEssam A. HassanAmal A. IbrahimDoaa Y. AliMohamed M. MohamedOmayma O. AbdelaleemNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Rania H. Mahmoud Enas Mamdouh Hefzy Olfat G. Shaker Tarek I. Ahmed Noha K. Abdelghaffar Essam A. Hassan Amal A. Ibrahim Doaa Y. Ali Mohamed M. Mohamed Omayma O. Abdelaleem GAS5 rs2067079 and miR-137 rs1625579 functional SNPs and risk of chronic hepatitis B virus infection among Egyptian patients |
description |
Abstract Hepatitis B virus (HBV) infection is a significant health issue worldwide.. We attempted to fulfill the molecular mechanisms of epigenetic and genetic factors associated with chronic HBV (CHBV). Expression levels of the lncRNA growth arrest-specific 5 (GAS5) and miR-137 and their corresponding SNPs, rs2067079 (C/T) and rs1625579 (G/T) were analyzed in 117 CHBV patients and 120 controls to investigate the probable association between these biomarkers and CHBV pathogenesis in the Egyptian population. Serum expression levels of GAS5 and miR-137 were significantly down-regulated in cases vs controls. Regarding GAS5 (rs2067079), the mutant TT genotype showed an increased risk of CHBV (p < 0.001), while the dominant CC was a protective factor (p = 0.004). Regarding miR-137 rs1625579, the mutant genotype TT was reported as a risk factor for CHBV (p < 0.001) and the normal GG genotype was a protective factor, p < 0.001. The serum GAS5 was significantly higher in the mutant TT genotype of GAS5 SNP as compared to the other genotypes (p = 0.007). Concerning miR-137 rs1625579, the mutant TT genotype was significantly associated with a lower serum expression level of miR-137 (p = 0.018). We revealed the dysregulated expression levels of GAS5 and miR-137 linked to their functioning SNPs were associated with CHBV risk and might act as potential therapeutic targets. |
format |
article |
author |
Rania H. Mahmoud Enas Mamdouh Hefzy Olfat G. Shaker Tarek I. Ahmed Noha K. Abdelghaffar Essam A. Hassan Amal A. Ibrahim Doaa Y. Ali Mohamed M. Mohamed Omayma O. Abdelaleem |
author_facet |
Rania H. Mahmoud Enas Mamdouh Hefzy Olfat G. Shaker Tarek I. Ahmed Noha K. Abdelghaffar Essam A. Hassan Amal A. Ibrahim Doaa Y. Ali Mohamed M. Mohamed Omayma O. Abdelaleem |
author_sort |
Rania H. Mahmoud |
title |
GAS5 rs2067079 and miR-137 rs1625579 functional SNPs and risk of chronic hepatitis B virus infection among Egyptian patients |
title_short |
GAS5 rs2067079 and miR-137 rs1625579 functional SNPs and risk of chronic hepatitis B virus infection among Egyptian patients |
title_full |
GAS5 rs2067079 and miR-137 rs1625579 functional SNPs and risk of chronic hepatitis B virus infection among Egyptian patients |
title_fullStr |
GAS5 rs2067079 and miR-137 rs1625579 functional SNPs and risk of chronic hepatitis B virus infection among Egyptian patients |
title_full_unstemmed |
GAS5 rs2067079 and miR-137 rs1625579 functional SNPs and risk of chronic hepatitis B virus infection among Egyptian patients |
title_sort |
gas5 rs2067079 and mir-137 rs1625579 functional snps and risk of chronic hepatitis b virus infection among egyptian patients |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/f70bc44957ef46e89717d93b6c4b3c51 |
work_keys_str_mv |
AT raniahmahmoud gas5rs2067079andmir137rs1625579functionalsnpsandriskofchronichepatitisbvirusinfectionamongegyptianpatients AT enasmamdouhhefzy gas5rs2067079andmir137rs1625579functionalsnpsandriskofchronichepatitisbvirusinfectionamongegyptianpatients AT olfatgshaker gas5rs2067079andmir137rs1625579functionalsnpsandriskofchronichepatitisbvirusinfectionamongegyptianpatients AT tarekiahmed gas5rs2067079andmir137rs1625579functionalsnpsandriskofchronichepatitisbvirusinfectionamongegyptianpatients AT nohakabdelghaffar gas5rs2067079andmir137rs1625579functionalsnpsandriskofchronichepatitisbvirusinfectionamongegyptianpatients AT essamahassan gas5rs2067079andmir137rs1625579functionalsnpsandriskofchronichepatitisbvirusinfectionamongegyptianpatients AT amalaibrahim gas5rs2067079andmir137rs1625579functionalsnpsandriskofchronichepatitisbvirusinfectionamongegyptianpatients AT doaayali gas5rs2067079andmir137rs1625579functionalsnpsandriskofchronichepatitisbvirusinfectionamongegyptianpatients AT mohamedmmohamed gas5rs2067079andmir137rs1625579functionalsnpsandriskofchronichepatitisbvirusinfectionamongegyptianpatients AT omaymaoabdelaleem gas5rs2067079andmir137rs1625579functionalsnpsandriskofchronichepatitisbvirusinfectionamongegyptianpatients |
_version_ |
1718377007997255680 |